← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Annexon, Inc.
South San Francisco, CA
$1,524,755
Total funding
3
Grants
Funding over time
peak $1.2M · FY2012–21$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,380,915 · 2
DOD$143,840 · 1
By mechanism
R44$1,213,915 · 1
R43$167,000 · 1
—$143,840 · 1
Investigators at Annexon, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of novel inhibitors of C1q for the treatment of Neurodegenerative diseases$1,213,915
R44 · FY2016 · AG
Development of novel inhibitors of complement for the treatment of Alzheimer's Di$167,000
R43 · FY2012 · AG
THE EFFECT OF ANX005, AN ANTI-C1Q ANTIBODY, ON BIOMARKERS OF TARGET AND PATHWAY ENGAGEMENT AND NEURODEGENERATION IN ALS PATIENTS$143,840
· FY2021 · Defense Health Agency